- Home
- CRGY vs HTGC Comparison
CRGY vs HTGC Comparison
Compare CRGY & HTGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | CRGY | HTGC |
|---|---|---|
| Founded | 1986 | 2003 |
| Country | United States | United States |
| Employees | N/A | 50 |
| Industry | Oil & Gas Production | Investment Managers |
| Sector | Energy | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 2.8B |
| IPO Year | 2022 | N/A |
Fundamental Metrics
Financial Performance| Metric | CRGY | HTGC |
|---|---|---|
| Price | $12.02 | $14.56 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 6 |
| Target Price | $13.25 | ★ $19.25 |
| AVG Volume (30 Days) | ★ 7.9M | 4.0M |
| Earning Date | 05-06-2026 | 01-01-0001 |
| Dividend Yield | 4.08% | ★ 12.65% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | ★ $3,579,782,000.00 | N/A |
| Revenue This Year | $26.77 | $10.81 |
| Revenue Next Year | N/A | $4.57 |
| P/E Ratio | $99.08 | ★ $8.61 |
| Revenue Growth | ★ 22.14 | N/A |
| 52 Week Low | $6.83 | $13.77 |
| 52 Week High | $12.40 | $19.67 |
Technical Indicators
Market Signals| Indicator | CRGY | HTGC |
|---|---|---|
| Relative Strength Index (RSI) | 66.94 | 33.21 |
| Support Level | $8.29 | $13.77 |
| Resistance Level | $12.40 | $19.38 |
| Average True Range (ATR) | 0.55 | 0.50 |
| MACD | 0.07 | 0.04 |
| Stochastic Oscillator | 85.63 | 35.34 |
Price Performance
Historical ComparisonAbout CRGY Crescent Energy Company
Crescent Energy Co is an energy company committed to delivering value for shareholders through disciplined growth, acquisition ideas, and the consistent return of capital. Its long-life, balanced portfolio combines stable cash flows from low-decline production with deep, high-quality development inventory. The Company's investing and operating activities are focused in Texas and the Rocky Mountain region.
About HTGC Hercules Capital Inc.
Hercules Capital Inc is a specialty finance company focused on providing senior secured loans to high-growth, venture capital-backed, and institutional-backed companies in a variety of technology and life sciences industries. The company's primary business objectives are to increase its net income, net investment income, and net asset value (NAV) through its investments mainly in structured debt or senior secured debt instruments of venture capital-backed and institutional-backed companies across a variety of technology-related industries at attractive yields. It finances companies belonging to computer software and hardware, networking systems, semiconductors, medical devices, bio-pharmaceutical, and other related sectors.